Ebrahim Versi
Amministratore Delegato presso DMK PHARMACEUTICALS CORPORATION
Patrimonio netto: 262 $ in data 31/05/2024
Posizioni attive di Ebrahim Versi
Società | Posizione | Inizio | Fine |
---|---|---|---|
DMK PHARMACEUTICALS CORPORATION | Amministratore Delegato | 25/05/2023 | - |
Presidente | 25/05/2023 | - | |
Royal College of Obstetricians & Gynaecologists | Corporate Officer/Principal | - | - |
Versi Group LLC | Presidente | - | - |
Storia della carriera di Ebrahim Versi
Precedenti posizioni note di Ebrahim Versi
Società | Posizione | Inizio | Fine |
---|---|---|---|
Mt. Cook Pharma, Inc.
Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mt. Cook Pharma, Inc. provides treatment for urological diseases. It offers services to overactive bladder, lower urinary symptoms, and interstitial cystitis diseases. The company was headquartered in Princeton, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | - |
Plethora Solutions Plc | Corporate Officer/Principal | 01/01/2006 | - |
PFIZER, INC. | Corporate Officer/Principal | 01/01/1999 | - |
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Amministratore Delegato | 01/06/2016 | - |
Presidente | 01/06/2016 | - | |
Fondatore | 01/06/2016 | - | |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | Fondatore | 01/06/2013 | - |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Direttore/Membro del Consiglio | 01/02/2015 | - |
Amministratore Delegato | 01/02/2015 | - | |
░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░░ ░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Ebrahim Versi
University of Oxford | Doctorate Degree |
University of Cambridge | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Regno Unito | 4 |
Posizioni
Corporate Officer/Principal | 5 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Settori
Health Technology | 7 |
Consumer Services | 5 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
PFIZER, INC. | Health Technology |
DMK PHARMACEUTICALS CORPORATION | Health Technology |
Aziende private | 9 |
---|---|
Mt. Cook Pharma, Inc.
Mt. Cook Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mt. Cook Pharma, Inc. provides treatment for urological diseases. It offers services to overactive bladder, lower urinary symptoms, and interstitial cystitis diseases. The company was headquartered in Princeton, NJ. | Health Technology |
Dignify Therapeutics LLC
Dignify Therapeutics LLC Pharmaceuticals: MajorHealth Technology Dignify Therapeutics LLC offers pharmaceutical services. It provides bladder and bowel for people who have spinal cord injury. The company was founded by Edward C. Burgard, Karl B. Thor, Lesley Marson, Venkateswarlu Karicheti, Daniel J. Ricca, Florenta Aura Kullmann, Ebrahim Versi, Benny L. Ward, Tatyana Touzova and Mary Katofiasc and is headquartered in Research Triangle Park, NC. | Health Technology |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Health Technology |
Plethora Solutions Plc | |
Yamanouchi Pharma America, Inc. | |
Veris Consulting, Inc.
Veris Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Veris Consulting, Inc. provides forensic accounting services. The firm offers consulting services in forensic accounting, litigation support, accounting consulting and business research. The company was founded by Larry R. Johnson in 2000 and is headquartered in Reston, VA. | Commercial Services |
Versi Group LLC | |
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Health Technology |
- Borsa valori
- Insiders
- Ebrahim Versi
- Esperienza